A study by Vasmatzis et al. also suggested that a series of genetic mutations and epigenetic abnormalities may conduce destruction of p53-associated tumor suppressor function in PTCL [26]. This evidence concerns the gene TP53 and mature T-cell and NK-cell non-Hodgkin lymphoma.